Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The prevalence of AD is increasing and is currently estimated at 10–20% in adults worldwide. In the majority of patients, AD can be adequately controlled with topical treatment or ultraviolet light therapy, but ther...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Chronic Dis
Main Authors: Ariëns, Lieneke F.M., Bakker, Daphne S., van der Schaft, Jorien, Garritsen, Floor M., Thijs, Judith L., de Bruin-Weller, Marjolein S.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6116085/
https://ncbi.nlm.nih.gov/pubmed/30181845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622318773686
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados